Shibani Pati
About
Shibani Pati is a scholar working on Critical Care and Intensive Care Medicine, Emergency Medicine and Epidemiology.
According to data from OpenAlex, Shibani Pati has authored 106 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Critical Care and Intensive Care Medicine, 37 papers in Emergency Medicine and 23 papers in Epidemiology. Recurrent topics in Shibani Pati's work include Trauma, Hemostasis, Coagulopathy, Resuscitation (47 papers), Trauma and Emergency Care Studies (33 papers) and Mesenchymal stem cell research (22 papers). Shibani Pati is often cited by papers focused on Trauma, Hemostasis, Coagulopathy, Resuscitation (47 papers), Trauma and Emergency Care Studies (33 papers) and Mesenchymal stem cell research (22 papers). Shibani Pati collaborates with scholars based in United States, Germany and Netherlands. Shibani Pati's co-authors include John B. Holcomb, Rosemary A. Kozar, Marvin S. Reitz, Pramod K. Dash, Zhanglong Peng, Aarif Y. Khakoo, Daniel Potter, Charles E. Wade, Charles S. Cox and Martin A. Schreiber and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.
In The Last Decade
Shibani Pati
105 papers receiving 5.6k citations
Hit Papers
Peers
Shibani Pati
Tatu Juvonen Finland
Jaap Jan Zwaginga Netherlands
Peter R. Mertens Germany
Jan Rossaint Germany
Jae Woo Lee United States
Hendrik Jan Ankersmit Austria
Naphtali Savion Israel
Xiaohui Fang United States
Timothy M. Carlos United States
Joshua M. Thurman United States
Citations per year, relative to Shibani Pati Shibani Pati (= 1×)
peers
Tatu Juvonen
Countries citing papers authored by Shibani Pati
Since
Specialization
Citations
This map shows the geographic impact of Shibani Pati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibani Pati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibani Pati more than expected).
Fields of papers citing papers by Shibani Pati
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Shibani Pati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibani Pati. The network helps show where Shibani Pati may publish in the future.
Co-authorship network of co-authors of Shibani Pati
This figure shows the co-authorship network connecting the top 25 collaborators of Shibani Pati. A scholar is included among the top collaborators of Shibani Pati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibani Pati. Shibani Pati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mamo, Tewodros, Cheryl A. Cox, Magali J. Fontaine, et al.. (2024). Cryopreservation of mesenchymal stem/stromal cells using a DMSO-free solution is comparable to DMSO-containing cryoprotectants: results of an international multicenter PACT/BEST collaborative study. Cytotherapy. 26(12). 1522–1531.
2.
Trivedi, Alpa, Byron Miyazawa, Xiaohui Fang, et al.. (2024). Inter- and Intra-donor variability in bone marrow–derived mesenchymal stromal cells: implications for clinical applications. Cytotherapy. 26(9). 1062–1075.
3.
Cuschieri, Joseph, Lucy Z. Kornblith, Shibani Pati, & Adrian M. Piliponsky. (2023). The injured monocyte: The link to chronic critical illness and mortality following injury. The Journal of Trauma: Injury, Infection, and Critical Care. 96(2). 195–202.
4.
Shaz, Beth H., Richard Schäfer, Magali J. Fontaine, et al.. (2023). Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative study. Cytotherapy. 26(6). 531–539.
5.
Zeineddin, Ahmad, Feng Wu, Wei Chao, et al.. (2022). Biomarkers of endothelial cell dysfunction persist beyond resuscitation in patients with hemorrhagic shock. The Journal of Trauma: Injury, Infection, and Critical Care. 93(5). 572–578.
6.
Miyazawa, Byron, Alpa Trivedi, Daniel Potter, et al.. (2022). Histone deacetylase-6 modulates the effects of 4°C platelets on vascular endothelial permeability. Blood Advances. 7(7). 1241–1257.
7.
Barry, Mark, et al.. (2022). Lyophilized plasma resuscitation downregulates inflammatory gene expression in a mouse model of sepsis. The Journal of Trauma: Injury, Infection, and Critical Care. 93(2S). S119–S127.
8.
Herzig, Maryanne C., Barbara A. Christy, Richard Schäfer, et al.. (2021). Neglected No More: Emerging Cellular Therapies in Traumatic Injury. Stem Cell Reviews and Reports. 17(4). 1194–1214.
9.
Stroncek, David F., Ping Jin, David H. McKenna, et al.. (2020). Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Frontiers in Cell and Developmental Biology. 8. 458–458.
10.
Potter, Daniel, Alpa Trivedi, Byron Miyazawa, et al.. (2020). The effects of human prothrombin complex concentrate on hemorrhagic shock-induced lung injury in rats: Implications for testing human blood products in rodents. The Journal of Trauma: Injury, Infection, and Critical Care. 89(6). 1068–1075.
11.
Miyazawa, Byron, Alpa Trivedi, Padma Priya Togarrati, et al.. (2019). Regulation of endothelial cell permeability by platelet-derived extracellular vesicles. The Journal of Trauma: Injury, Infection, and Critical Care. 86(6). 931–942.
12.
Bieback, Karen, Beatriz Fernández‐Muñoz, Shibani Pati, & Richard Schäfer. (2019). Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy. Cytotherapy. 21(9). 911–924.
13.
Jones, James M., Marc A. DePaul, Bradley T. Lang, et al.. (2018). Multipotent Adult Progenitor Cells, but Not Tissue Inhibitor of Matrix Metalloproteinase-3, Increase Tissue Sparing and Reduce Urological Complications following Spinal Cord Injury. Journal of Neurotrauma. 36(9). 1416–1427.
14.
Potter, Daniel, Byron Miyazawa, Stuart L. Gibb, et al.. (2017). Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma. The Journal of Trauma: Injury, Infection, and Critical Care. 84(2). 245–256.
15.
Baimukanova, Gyulnar, Byron Miyazawa, Daniel Potter, et al.. (2016). The effects of 22°C and 4°C storage of platelets on vascular endothelial integrity and function. Transfusion. 56(S1). S52–64.
16.
Menge, Tyler D., Michael H. Gerber, Kathryn Wataha, et al.. (2012). Human Mesenchymal Stem Cells Inhibit Endothelial Proliferation and Angiogenesis via Cell–Cell Contact Through Modulation of the VE-Cadherin/β-Catenin Signaling Pathway. Stem Cells and Development. 22(1). 148–157.
17.
Holcomb, John B., Lee Ann Zarzabal, Joel Michalek, et al.. (2011). Increased Platelet:RBC Ratios Are Associated With Improved Survival After Massive Transfusion. The Journal of Trauma: Injury, Infection, and Critical Care. 71(2). S318–S328.
18.
Walker, Peter A., Matthew T. Harting, Fernando Jiménez, et al.. (2009). Direct Intrathecal Implantation of Mesenchymal Stromal Cells Leads to Enhanced Neuroprotection via an NFκB-Mediated Increase in Interleukin-6 Production. Stem Cells and Development. 19(6). 867–876.
19.
Khakoo, Aarif Y., Shibani Pati, Stasia A. Anderson, et al.. (2006). Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. The Journal of Experimental Medicine. 203(5). 1235–1247.
20.
Pati, Shibani, et al.. (2002). Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma. Blood. 99(10). 3771–3779.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Tatu Juvonen Breakdown of academic impact, for papers by Jaap Jan Zwaginga Breakdown of academic impact, for papers by Peter R. Mertens Breakdown of academic impact, for papers by Jan Rossaint Breakdown of academic impact, for papers by Jae Woo Lee Breakdown of academic impact, for papers by Hendrik Jan Ankersmit Breakdown of academic impact, for papers by Naphtali Savion Breakdown of academic impact, for papers by Xiaohui Fang Breakdown of academic impact, for papers by Timothy M. Carlos Breakdown of academic impact, for papers by Joshua M. Thurman